Bio-Rad Laboratories BIO
NYSE BIO
$366.15 -4.35 (-1.17%)
At close: Nov 13, 2026 · 4:00 PM EST

Bio-Rad Laboratories (BIO) Cash from Operations (2009 - 2026)

Updated

Bio-Rad Laboratories (BIO) posted Cash from Operations of $96.4 million for Q3 2026, down 20.3% from $120.9 million a year earlier and down 2.3% from the prior quarter.

Analysis

Bio-Rad Laboratories (BIO) Cash from Operations (2009 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Cash from Operations at Bio-Rad Laboratories was $468.1 million, down 4.8% year-over-year; for FY2025, it came in at $532.2 million, up 16.9% from FY2024.

  • Annual Cash from Operations has increased for three consecutive years, though with a five-year compound annual growth rate of -1.9% (FY2020 to FY2025).
  • In prior years, Bio-Rad Laboratories' Cash from Operations was $455.2 million in FY2024 (+21.4%), $374.9 million in FY2023 (+92.8%), $194.4 million in FY2022 (-71.0%) and $669.5 million in FY2021 (+14.4%).
  • The Q3 2026 figure stands as the lowest quarterly Cash from Operations since Q1 2024.
  • On a year-over-year basis, Cash from Operations has declined in each of the last three quarters, with growth averaging 14.1% over the last eight quarters.
  • The strongest year-over-year quarter for Cash from Operations in the past five years was Q3 2023, with growth of 788.2%; the weakest was Q3 2022, with a decline of 95.2%.
  • According to Business Quant data, Cash from Operations for the three prior quarters was $98.7 million (Q2 2026), $108.1 million (Q1 2026) and $164.9 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Thermo Fisher Scientific 259.44 Bn 236.08 Bn 5.13 Bn 2.55 Bn
2 Abbott Laboratories 187.98 Bn 162.45 Bn 7.39 Bn 1.74 Bn
3 Danaher 163.91 Bn 143.58 Bn 3.84 Bn 1.89 Bn
4 Intuitive Surgical 153.75 Bn 134.17 Bn 2.08 Bn 1.22 Bn
5 Medtronic 131.67 Bn 97.80 Bn 6.34 Bn 1.79 Bn
6 Stryker 117.84 Bn 104.03 Bn 4.25 Bn 1.46 Bn
7 Boston Scientific 64.27 Bn 59.95 Bn 3.43 Bn 1.05 Bn
8 Edwards Lifesciences 61.69 Bn 45.00 Bn 1.35 Bn 570.30 Mn
9 Medline 51.94 Bn 49.07 Bn 1.93 Bn 1.03 Bn
10 Bio-Rad Laboratories 9.85 Bn 3.46 Bn 328.60 Mn 96.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 96.40 Mn
Jun 30, 2026 98.70 Mn
Mar 31, 2026 108.10 Mn
Dec 31, 2025 164.90 Mn
Sep 30, 2025 120.90 Mn
Jun 30, 2025 116.50 Mn
Mar 31, 2025 129.90 Mn
Dec 31, 2024 124.20 Mn
Sep 30, 2024 163.60 Mn
Jun 30, 2024 97.60 Mn
Mar 31, 2024 69.80 Mn
Dec 31, 2023 81.00 Mn
Sep 30, 2023 97.70 Mn
Jun 30, 2023 98.08 Mn
Mar 31, 2023 98.12 Mn
Dec 31, 2022 79.60 Mn
Sep 30, 2022 11.00 Mn
Jun 30, 2022 53.30 Mn
Mar 31, 2022 50.50 Mn
Dec 31, 2021 170.90 Mn
API Access

Bio-Rad Laboratories Cash from Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-operations&ticker=BIO&period=max&api_key=YOUR_API_KEY